Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey multicenter cancer patients (2020-2022).

Caglar UnalGülşah TunçerBetül Sadıç ÇopurKezban Nur PilanciKerem Sadi OkuturKanay YararbaşÖzkan AlanAbdullah SakinMelih Simsekİpek Özönder ÜnalAtakan TopçuZeynep Alaca TopçuTomris DuymazÇetin Ordu

Published in: Current medical research and opinion (2023)

This is the first study to investigate the distribution and characteristics of cancer patients diagnosed with COVID-19. Based on the data from our study, bilateral lung involvement is an independent factor for severe disease, and the CRP/L inflammation index appears to be the most reliable prognostic marker.

Keyphrases

oxidative stress
coronavirus disease
electronic health record
clinical trial
cross sectional
drug induced
artificial intelligence